Literature DB >> 9715152

Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence?

N R Hall1, P J Finan, T al-Jaberi, C S Tsang, S R Brown, M F Dixon, P Quirke.   

Abstract

PURPOSE: This study examines the prognostic significance of circumferential margin involvement by tumor in resected specimens after potentially curative rectal cancer surgery.
METHODS: During an eight-year period, all patients with rectal cancer were prospectively audited. For tumors of the middle and lower thirds of the rectum, a total mesorectal excision was performed; for tumor of the upper third, mesorectal excision proceeded at least 5 cm distal to the primary tumor. Resected specimens were subjected to careful histologic assessment, and patients undergoing curative procedures were entered into a surveillance program to detect both local and distant recurrence.
RESULTS: Of 218 patients in the cohort, 9 had no resection, 14 underwent local excision, 1 had pre-operative radiotherapy, and 42 patients (20 percent) had palliative resections and were excluded from further analysis. This left 152 patients having a curative resection, of whom 20 (13 percent) had tumor within 1 mm of the circumferential margin. After follow-up until death or a median period of 41 months, recurrent disease was seen in 24 percent of patients with a negative margin and 50 percent with a positive margin. Both disease-free survival and mortality were significantly related to margin involvement (log-rank, P = 0.01 and P = 0.005, respectively). Local recurrence, however, was not significantly different in the two groups (11 and 15 percent, respectively; log-rank, P = 0.38).
CONCLUSIONS: When mesorectal excision is performed, circumferential margin involvement is more an indicator of advance disease than inadequate local surgery. Patients with an involved margin may die from distant disease before local recurrence becomes apparent.

Entities:  

Mesh:

Year:  1998        PMID: 9715152     DOI: 10.1007/bf02237384

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  49 in total

1.  Prognostic inhomogeneity in pT3 rectal carcinomas: comment.

Authors:  Susanne Merkel
Journal:  Int J Colorectal Dis       Date:  2002-05       Impact factor: 2.571

2.  Total mesorectal excision for rectal cancer: the truth lies underneath.

Authors:  Jesús A Fernández-Represa; Julio M Mayol; Julio Garcia-Aguilar
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

Review 3.  Update on the surgical pathology standards on rectal cancer diagnosis, staging and quality assessment of surgery.

Authors:  Alejandro Rojo; Pilar Sancho; Oscar Alonso; Sara Encinas; Gemma Toledo; Juan F García
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

4.  Using p53-immunostained large specimens to determine the distal intramural spread margin of rectal cancer.

Authors:  Zhi-Zhong Pan; De-Sen Wan; Chang-Qing Zhang; Jian-Yong Shao; Li-Ren Li; Gong Chen; Zhi-Wei Zhou; Fu-Long Wang
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

5.  Consensus statement: the 16th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Saskatoon, Saskatchewan; September 5-6, 2014.

Authors:  S Ahmed; O Bathe; S Berry; D Buie; J Davies; C Doll; S Dowden; S Gill; V Gordon; P Hebbard; E Jones; H Kennecke; S Koski; M Krahn; D Le; H Lim; C Lund; Y Luo; A Mcffadden; J Mcghie; K Mulder; J Park; F Rashidi; A Sami; K T Tan; R Wong
Journal:  Curr Oncol       Date:  2015-04       Impact factor: 3.677

6.  What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy?

Authors:  Atthaphorn Trakarnsanga; Mithat Gonen; Jinru Shia; Karyn A Goodman; Garrett M Nash; Larissa K Temple; José G Guillem; Philip B Paty; Julio Garcia-Aguilar; Martin R Weiser
Journal:  Ann Surg Oncol       Date:  2013-01-18       Impact factor: 5.344

7.  Clinical and oncologic outcomes of totally robotic total mesorectal excision for rectal cancer: initial results in a center for minimally invasive surgery.

Authors:  Chang-Nam Kim; Sung Uk Bae; Seul-Gi Lee; Seung Hyun Yang; In Gun Hyun; Je Ho Jang; Byung Sun Cho; Joo Seung Park
Journal:  Int J Colorectal Dis       Date:  2016-03-09       Impact factor: 2.571

8.  Multidisciplinary teams in the management of rectal cancer.

Authors:  Vincent J Obias; Harry L Reynolds
Journal:  Clin Colon Rectal Surg       Date:  2007-08

9.  Sphincter-sparing resection for rectal cancer.

Authors:  Kirk A Ludwig
Journal:  Clin Colon Rectal Surg       Date:  2007-08

10.  The pathologist's role in rectal cancer patient assessments.

Authors:  Joseph E Willis
Journal:  Clin Colon Rectal Surg       Date:  2007-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.